Based on the findings, injection of mGluR2/3 antagonist in the striatum increased the concentration of extracellular Glu in striatal neurons and prevented the efficacy of exercise in alleviating motor dysfunction in the rat PD model. The gene discussed is GRM2; the disease is Parkinson disease.